Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 237

1.

Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease.

White HK, Levin ED.

Psychopharmacology (Berl). 1999 Apr;143(2):158-65.

PMID:
10326778
[PubMed - indexed for MEDLINE]
2.

Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment.

White HK, Levin ED.

Psychopharmacology (Berl). 2004 Feb;171(4):465-71. Epub 2003 Oct 8.

PMID:
14534771
[PubMed - indexed for MEDLINE]
3.

The effects of nicotine in dermal plaster on cognitive functions in patients with Alzheimer's disease.

Snaedal J, Johannesson T, Jonsson JE, Gylfadottir G.

Dementia. 1996 Jan-Feb;7(1):47-52.

PMID:
8788082
[PubMed - indexed for MEDLINE]
4.

Nicotine patches in Alzheimer's disease: pilot study on learning, memory, and safety.

Wilson AL, Langley LK, Monley J, Bauer T, Rottunda S, McFalls E, Kovera C, McCarten JR.

Pharmacol Biochem Behav. 1995 Jun-Jul;51(2-3):509-14.

PMID:
7667377
[PubMed - indexed for MEDLINE]
5.

The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls.

Barr RS, Culhane MA, Jubelt LE, Mufti RS, Dyer MA, Weiss AP, Deckersbach T, Kelly JF, Freudenreich O, Goff DC, Evins AE.

Neuropsychopharmacology. 2008 Feb;33(3):480-90. Epub 2007 Apr 18.

PMID:
17443126
[PubMed - indexed for MEDLINE]
Free Article
6.

Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study.

Asthana S, Craft S, Baker LD, Raskind MA, Birnbaum RS, Lofgreen CP, Veith RC, Plymate SR.

Psychoneuroendocrinology. 1999 Aug;24(6):657-77.

PMID:
10399774
[PubMed - indexed for MEDLINE]
7.

Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits.

Poltavski DV, Petros T.

Physiol Behav. 2006 Mar 30;87(3):614-24. Epub 2006 Feb 7.

PMID:
16466655
[PubMed - indexed for MEDLINE]
8.

Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial.

McClernon FJ, Hiott FB, Westman EC, Rose JE, Levin ED.

Psychopharmacology (Berl). 2006 Nov;189(1):125-33. Epub 2006 Sep 15.

PMID:
16977477
[PubMed - indexed for MEDLINE]
9.

Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease.

Lemay S, Chouinard S, Blanchet P, Masson H, Soland V, Beuter A, B├ędard MA.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):31-9.

PMID:
14687854
[PubMed - indexed for MEDLINE]
10.

Transdermal nicotine effects on attention.

Levin ED, Conners CK, Silva D, Hinton SC, Meck WH, March J, Rose JE.

Psychopharmacology (Berl). 1998 Nov;140(2):135-41.

PMID:
9860103
[PubMed - indexed for MEDLINE]
11.

Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder.

Potter AS, Newhouse PA.

Pharmacol Biochem Behav. 2008 Feb;88(4):407-17. Epub 2007 Sep 26.

PMID:
18022679
[PubMed - indexed for MEDLINE]
12.

Effects of transdermal nicotine on attention and memory in healthy elderly non-smokers.

Min SK, Moon IW, Ko RW, Shin HS.

Psychopharmacology (Berl). 2001 Dec;159(1):83-8. Epub 2001 Sep 15.

PMID:
11797074
[PubMed - indexed for MEDLINE]
13.

Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.

Atzori G, Lemmonds CA, Kotler ML, Durcan MJ, Boyle J.

J Clin Psychopharmacol. 2008 Dec;28(6):667-74. doi: 10.1097/JCP.0b013e31818c9bb8.

PMID:
19011436
[PubMed - indexed for MEDLINE]
14.

The effects of nicotine on Parkinson's disease.

Kelton MC, Kahn HJ, Conrath CL, Newhouse PA.

Brain Cogn. 2000 Jun-Aug;43(1-3):274-82.

PMID:
10857708
[PubMed - indexed for MEDLINE]
15.

Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease.

Johannsen P, Salmon E, Hampel H, Xu Y, Richardson S, Qvitzau S, Schindler R; AWARE Study Group.

CNS Drugs. 2006;20(4):311-25. Erratum in: CNS Drugs. 2006;20(10):866.

PMID:
16599649
[PubMed - indexed for MEDLINE]
16.

Nicotine-haloperidol interactions and cognitive performance in schizophrenics.

Levin ED, Wilson W, Rose JE, McEvoy J.

Neuropsychopharmacology. 1996 Nov;15(5):429-36.

PMID:
8914115
[PubMed - indexed for MEDLINE]
Free Article
17.

Effects of the nicotine patch on performance during the first week of smoking cessation.

Cook MR, Gerkovich MM, Graham C, Hoffman SJ, Peterson RC.

Nicotine Tob Res. 2003 Apr;5(2):169-80. Review.

PMID:
12745489
[PubMed - indexed for MEDLINE]
18.

Cognitive effects of nicotine.

Rezvani AH, Levin ED.

Biol Psychiatry. 2001 Feb 1;49(3):258-67. Review.

PMID:
11230877
[PubMed - indexed for MEDLINE]
19.

Differential improvement in memory-related task performance with nicotine by aged male and female rhesus monkeys.

Buccafusco JJ, Jackson WJ, Jonnala RR, Terry AV Jr.

Behav Pharmacol. 1999 Nov;10(6-7):681-90.

PMID:
10780510
[PubMed - indexed for MEDLINE]
20.

Effects of transdermal nicotine on cognitive performance in Down's syndrome.

Seidl R, Tiefenthaler M, Hauser E, Lubec G.

Lancet. 2000 Oct 21;356(9239):1409-10.

PMID:
11052587
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk